Case Control Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Mar 21, 2015; 21(11): 3266-3273
Published online Mar 21, 2015. doi: 10.3748/wjg.v21.i11.3266
Table 1 Clinical characteristics, n
Transplant patientsHD patientsGeneral population
Total120231450
Sex (male:female)82:38126:105178:272
Median age (yr)486340
Causes of renal failureChronic glomerulonephritis: 43Chronic glomerulonephritis: 73
Nephroangiosclerosis: 21Nephroangiosclerosis: 27
Polycystic kidney disease: 16Polycystic kidney disease: 32
Diabetic nephropathy: 14Diabetic nephropathy: 44
Chronic interstitial nephritis: 11Chronic interstitial nephritis: 26
Other aetiologies: 15Other aetiologies: 29
Median HD treatment18 mo (range: 1-54 mo)79 mo (range: 3-154 mo)
17 mo (range: 1-48 mo) HEV-negative78.9 mo (range: 3-149 mo) HEV-negative
21 mo (range: 3-54 mo) HEV-positive81 mo (range: 7-154 mo) HEV-positive
Immunosuppressive treatmentAll of the patients (120)Yes: 2 (males)
Table 2 Hepatitis E virus antibodies n (%)
Transplant patientsHD patientsGeneral population
Total120231450
Anti-HEV Ig pos.4 (3.3)14 (6)12 (2.7)
HEV IgM pos.121
HEV RNA pos.231